Neuroone Medical Technologies (NMTC) Return on Capital Employed (2011 - 2026)
Neuroone Medical Technologies (NMTC) posted Return on Capital Employed of 115.33% for Q1 2026, down 27.07% on a QoQ basis from 90.76% in Q4 2025, and up 6191.0% year-over-year from 1.83% in Q1 2025.
Neuroone Medical Technologies (NMTC) Return on Capital Employed (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies' Return on Capital Employed history runs 15 years deep, the most recent figure standing at 115.33% for Q1 2026.
- Quarterly Return on Capital Employed rose 6191.0% year-over-year to 115.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 115.33% (up 6191.0% YoY) and the FY2025 annual result came in at 73.19%, up 18978.0% from the prior year.
- Return on Capital Employed was 115.33% for Q1 2026 at Neuroone Medical Technologies, down from 90.76% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 49.73% in Q3 2025 and bottomed at 405.98% in Q3 2024.
- A 5-year average of 174.06% and a median of 137.19% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed sank 18117 bps — and 2025, when it jumped 35625 bps.
- Neuroone Medical Technologies' Return on Capital Employed stood at 90.91% in 2022, then plunged by 168 bps to 243.18% in 2023, then jumped by 36 bps to 155.59% in 2024, then jumped by 42 bps to 90.76% in 2025, then dropped by 27 bps to 115.33% in 2026.
- Business Quant data shows NMTC's Return on Capital Employed at 115.33% in Q1 2026, 90.76% in Q4 2025, and 49.73% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | -115.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115.33% |
| Dec 31, 2025 | -90.76% |
| Sep 30, 2025 | -49.73% |
| Jun 30, 2025 | -91.31% |
| Mar 31, 2025 | -177.24% |
| Dec 31, 2024 | -155.59% |
| Sep 30, 2024 | -405.98% |
| Jun 30, 2024 | -353.33% |
| Mar 31, 2024 | -318.36% |
| Dec 31, 2023 | -243.18% |
| Sep 30, 2023 | -232.81% |
| Jun 30, 2023 | -215.28% |
| Mar 31, 2023 | -137.19% |
| Dec 31, 2022 | -90.91% |
| Sep 30, 2022 | -110.25% |
| Jun 30, 2022 | -93.84% |
| Mar 31, 2022 | -77.89% |
| Dec 31, 2021 | -94.66% |
| Sep 30, 2021 | -132.84% |
| Jun 30, 2021 | -76.03% |